Drugs already licensed could be trialled to potentially treat secondary brain cancer, new research finds29 November 2023The largest review of papers for brain cancer that has spread from the lungs has found abnormalities in the brain cancer and for which licensed drugs could be clinically trialled to find out if they could treat the disease. The research led by the University of Bristol and published in Neuro-Oncology Advances also found genetic differences between smokers and non-smokers.
Biosciences and AI merge with launch of new UKRI Network6 November 2023Bringing artificial intelligence (AI) and biosciences together to tackle major societal challenges is the aim of a new five-year £1.6m project involving the University of Bristol and several other UK universities.
Groundbreaking genomics project will improve global diversity in population health insight13 October 2023An international collaboration is aiming to improve global health by uncovering the effects of genomic and environmental diversity on differences in disease risk observed across the global population, thanks to a new partnership of 20 research groups from around the world.
Academic Respiratory Unit receives prestigious clinical academic funding11 August 2023Three clinicians based in the Academic Respiratory Unit (ARU) have been successful in gaining prestigious and highly competitive clinical academic funding from the National Institute for Health and Care Research (NIHR) and the Medical Research Council (MRC).
New Bristol Evidence Synthesis Group awarded £2.5m27 July 2023A new University of Bristol-based evidence synthesis team has been awarded £2.5 million from the National Institute for Health and Care Research (NIHR).
The Bristol Cancer Research Network's Early Career Researchers' symposium 202329 June 2023The University of Bristol's Cancer Research Network hosted its second annual symposium dedicated to early career researchers. The event showcased the extraordinary and diverse research being conducted by postgraduate students, postdoctoral researchers, clinical fellows and trainees across Bristol and the South-West.
Wearable monitor detects stress hormone levels across a full 24-hour day21 June 2023Early warning signs of diseases caused by dysfunctional levels of stress hormones could be spotted more easily thanks to a new wearable device developed by endocrine researchers. This is the first time it has been possible to measure changes to people’s stress hormones as they go about normal daily activities, across both day and night. The new collaborative research led by the University of Bristol, University of Birmingham and University of Bergen has the potential to revolutionise how diseases of the stress hormone system are diagnosed and treated.
Exploring the importance of participating in everyday life while dying13 June 2023The adaptations people of working age with advanced cancer make so they can continue participating in everyday life are explored in a paper published in Palliative Medicine. The paper, ‘The intentional pursuit of everyday life while dying’, is from NIHR ARC West’s Dr Julie Brose’s PhD at the Research Centre for Palliative Care, Death and Dying.
Delaying treatment for localised prostate cancer does not increase mortality risk, trial shows13 March 2023Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind today. The latest findings from the ProtecT trial, led by the Universities of Oxford and Bristol, are presented today at the European Association of Urology (EAU) Congress in Milan and published in the New England Journal of Medicine.
Working together to fight cancer27 January 2023On 25 January 2023 the Bristol Cancer Research Network invited 17 researchers and clinicians to present on projects that are looking to prevent, detect and treat cancer - by working with someone outside their own field of expertise. These collaborations are expected to, or are already providing, real-world applications to combat this dreadful disease.